Diastereoselective synthesis and configuration-dependent activity of (3-substituted-cycloalkyl)glycine pyrrolidides and thiazolidides as dipeptidyl peptidase IV inhibitors

被引:28
作者
Ashton, WT
Dong, H
Sisco, RM
Doss, GA
Leiting, B
Patel, RA
Wu, JK
Marsilio, F
Thornberry, NA
Weber, AE
机构
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Preclin Drug Metab, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA
关键词
D O I
10.1016/j.bmcl.2003.12.013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A diastereoselective synthesis was used to prepare a series of (3-substituted-cyclopentyl and -cyclohexyl)glycine pyrrolidides and thiazolidides. The three chiral centers were generated in an unambiguous, stereochemically defined manner. Inhibitory activity was dependent on the configuration at each stereocenter and on the nature of the 3-substituent. In the cyclopentylglycine pyrrolidide series, high potency against dipeptidyl peptidase IV and good selectivity could be achieved. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:859 / 863
页数:5
相关论文
共 31 条
  • [1] Augustyns K, 1999, CURR MED CHEM, V6, P311
  • [2] AUGUSTYNS K, 2003, EXPERT OPIN INV DRUG, V13, P2003
  • [3] The multifunctional or moonlighting protein CD26/DPPIV
    Boonacker, E
    Van Noorden, CJF
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 2003, 82 (02) : 53 - 73
  • [4] Structure-function of the glucagon receptor family of G protein-coupled receptors: The glucagon, GIP, GLP-1, and GLP-2 receptors
    Brubaker, PL
    Drucker, DJ
    [J]. RECEPTORS & CHANNELS, 2002, 8 (3-4) : 179 - 188
  • [5] DPPIV, seprase, and related serine peptidases in multiple cellular functions
    Chen, WT
    Kelly, T
    Ghersi, G
    [J]. CELL SURFACE PROTEASES, 2003, 54 : 207 - 232
  • [6] The entero-insular axis in type 2 diabetes - incretins as therapeutic agents
    Creutzfeldt, W
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 : S288 - S303
  • [7] Proline specific peptidases
    Cunningham, DF
    O'Connor, B
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1343 (02): : 160 - 186
  • [8] Glucagon-like peptide-1: A basis for new approaches to the management of diabetes
    Deacon, CF
    Holst, JJ
    Carr, RD
    [J]. DRUGS OF TODAY, 1999, 35 (03) : 159 - 170
  • [9] DEMUTH HU, 1995, DIPEPTIDYL PEPTIDASE, V4, P1
  • [10] Glucagon-like peptide-1
    Doyle, ME
    Egan, JM
    [J]. RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 : 377 - 399